Interpace Biosciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2025
Total Assets: $33.8M
Liabilities Breakdown FY2025
Total Liabilities: $11.5M
Asset Breakdown
Total Assets: $33.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $2.5M | 7.4% |
| Accounts Receivable | $5.6M | 16.7% |
| Inventory | $1.1M | 3.3% |
| Property, Plant & Equipment | $1.4M | 4.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $23.1M | 68.4% |
Liabilities Breakdown
Total Liabilities: $11.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $983.0K | 8.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $10.5M | 91.4% |